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Peritoneal dialysis adequacy and risk of death. United States in the 1990s. Investigations by Owen et al
Background. The purpose of this study was to evaluate the [1], Parker et al [2], Collins et al [3], Hakim et al [4],
relationship between dialysis dose, patient characteristics, and and others have all demonstrated that mortality ratesmedical comorbidities on mortality in chronic peritoneal dial-
among hemodialysis patients decreased as dose of dial-ysis patients.
ysis increased in hemodialysis patients. These observa-Methods. This work comprised a study cohort of 1446 pa-
tients obtained from a random sample of chronic peritoneal tions were used in the development of guidelines by the
dialysis patients from each dialysis center in three southeastern National Kidney Foundation Dialysis Outcomes Quality
states. Data collected on a standardized form were used to Initiative (DOQI) [5] for a minimal dose of dialysis incalculate weekly Kt/V urea and creatinine clearance. Data were
hemodialysis patients. Efforts by individual end-stagelinked to Network files containing data on patient demographic
renal disease (ESRD) networks as well as by nationaland medical comorbidities.
Results. Both weekly Kt/V urea and creatinine clearance organizations such as the National Kidney Foundation
were measured at least once in only 60.5% of continuous ambu- (NKF) and the Health Care Financing Administration’s
latory peritoneal dialysis (CAPD) patients and 63.7% of cycler ESRD Core Indicators project have led to widespreadpatients. Among the 873 patients who had at least one calcula-
dissemination of these clinical performance measuresble adequacy measure, the mean (6SD) weekly Kt/V urea
and improvement in the dose of dialysis delivered towas 2.13 6 0.55, and the normalized mean weekly creatinine
clearance was 62.9 6 20.4 L/week/m2. During the seven month hemodialysis patients [6, 7].
period of follow-up, there were 140 deaths. In separate logistic Similar interest is now focused on the association be-
regression models that included all of the studied risk factors, tween dialysis adequacy and mortality among peritonealusing separate variables for the urinary and peritoneal compo-
dialysis (PD) patients. Several studies have shown thatnents of dialysis adequacy, each 10 L/week/1.73 m2 increase
the dialysis dose is also associated with survival amongin the urinary component of weekly creatinine clearance was
associated with a 40% decreased risk of death, and each 0.1 PD patients [8–10]. These observations have been incor-
unit increase in the urinary component of weekly Kt/V urea porated into the NKF-DOQI guideline recommendations
was associated with a 12% decreased risk of death. In contrast, [5]. In addition, data from the HCFA Core Indicatorsthe dialysate components of neither weekly creatinine clearance
project indicate that in late 1994 and early 1995 that onenor weekly Kt/V urea were predictive of death. Other factors
third of patients did not have an adequacy measure overthat were associated with an increased risk of death included
increasing age, diabetes mellitus as the cause of end-stage renal a six-month period and from in late 1995 and early 1996
disease (ESRD), and a history of myocardial infarction. that less than one third of patients received adequate
Conclusions. Residual renal function, as expressed by weekly dialysis as defined by the DOQI recommendationscreatinine clearance or Kt/V urea, is an important predictor of
[11, 12]. The purpose of this report is to describe thedeath in chronic peritoneal dialysis patients. The nonsignificant
adequacy of dialysis and the association between dosefindings regarding peritoneal clearances and mortality may pos-
sibly be secondary to the narrow range of peritoneal clearances of dialysis and mortality in a population-based sample
in this study cohort. of PD patients studied just prior to the publication of
the DOQI Guidelines.
Considerable attention has been focused on the ade-
METHODSquacy of dialysis dose in hemodialysis patients in the
Study setting
The study was carried out in a single ESRD NetworkKey words: dialysis dose, Kt/V urea, creatinine clearance, residual renal
function, hemodialysis. in the southeastern United States. One of the functions
of the ESRD Network is as a chronic disease surveillanceReceived for publication August 12, 1999
system that collects, analyzes, and reports informationand in revised form January 27, 2000
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a defined population. This information is used to support by standard methods, using data from 24-hour dialysate
and urine collections [14]. For Kt/V, residual renal func-quality improvement programs and peer review activities
designed and supervised by volunteer physicians and allied tion was calculated using urine urea clearance only. For
CCr, residual renal function was calculated to be the aver-health professionals serving on the Network’s Medical
Review Board. age of the urine urea and CCr. Volume (V) was determined
by the method of Watson, Watson, and Batt [15], and body
Study design surface area was calculated using the formula by duBois
and duBois [16]. If more than one adequacy measureThe study was a population-based, prospective follow-
up of a randomly selected population of patients treated was available during the six-month period, then the aver-
age of the adequacy value was used in all calculations.with PD.
Sample selection Adequacy definitions
Only measurements of PD adequacy made within sixAll facilities providing chronic PD in the fall of 1996
in a single ESRD Network serving North Carolina, South months of the date of the survey were considered, and
patients with no measurements within this period wereCarolina, and Georgia were included in the study. A
random sample of 30 PD patients within each facility assumed to have no adequacy measurement. Among pa-
tients with adequacy measurements, treatment was desig-was drawn and of all patients in facilities with fewer than
30 patients. nated adequate when calculated values for both weekly
Kt/V urea and weekly CCr met or exceeded DOQI-NKF
Data Guidelines as follows: for patients on CAPD, a Kt/V of
2.0 and CCr of 60 L/1.73 m2; for patients on cycler therapyA data collection form similar to that used for the 1996
Peritoneal Dialysis Core Indicators project was used [13]. with a daytime dwell, a Kt/V of 2.1 and CCr of 63 L/1.73
m2; and for patients on cycler therapy without a daytimeTreatment center staff recorded the most recent clinical
and treatment adequacy information for each patient. dwell, a Kt/V of 2.2 and CCr of 66 L/1.73 m2 [5].
Data collected included height and weight; 24-hour dialy-
Follow-upsate outflow volume, urea nitrogen, and creatinine; 24-
hour urine volume, urea nitrogen, and creatinine; blood Follow-up for each patient began at the time the sur-
vey form was completed by treatment center staff andurea nitrogen and serum creatinine measures concurrent
with dialysate and urine measures; and calculated values continued for seven months or until one of the following
events occurred: death, transplantation, change to hemo-of weekly Kt/V urea and creatinine clearance (CCr).
Information was recorded about each patient’s PD dialysis, or patient relocation out of the network.
prescription at the time that adequacy measures were
Data analysismade, including dwell volume and number of exchanges
for patients on continuous ambulatory peritoneal dialysis Differences in the proportion of patients with any ade-
quacy measurement and the proportion of patients with(CAPD), and dwell volumes, number of daytime and
nighttime exchanges, and dwell times for patients on adequacy measurements below DOQI-NKF Guidelines
across levels of demographic, clinical, and treatmentcontinuous cyclic peritoneal dialysis (CCPD).
Information was obtained from Network records near- characteristics were assessed for statistical significance
using chi-square tests. Then differences in mean dose ofest to the date of the survey about each patient at the
start of treatment, including age, sex, race, cause of renal dialysis were compared using analysis of variance [17].
Factors independently associated with either adequacyfailure, starting date of dialysis, and history of angina
pectoris, myocardial infarction, and congestive heart fail- measurement or inadequate dialysis were identified us-
ing separate logistic regression models [18]. Independenture. Because of the small numbers of other races (92
patients with race other than black or white and 72 pa- variables that were significantly associated with the out-
come were added to the models one at a time using atients with unknown race), only blacks and whites were
included in our analyses. In addition, data on serum forward stepwise technique. All tests of significance were
evaluated at the 0.05 error level.albumin levels obtained from another Network database
were included when available. We then examined the association between risk of
death and adequacy of PD dose. First, chi-square testsCause of renal failure was categorized as either diabe-
tes or all other causes. Body mass index (BMI) was were used to examine the association between patient
characteristics and risk of death. Second, the associationcalculated as weight in kilograms divided by height in
meters squared. The duration of dialysis was the number between dose of PD and risk of death was analyzed inde-
pendently for both measures of adequacy, weekly Kt/Vof years from the starting date of dialysis until the date
of the survey. and weekly CCr. Third, the associations between total
weekly Kt/V and weekly CCr and death after partitioningThe calculation of weekly Kt/V and CCr was performed
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these measures into a peritoneal clearance and a renal weekly CCr was 53.7 6 13.8 L/week/1.73 m2 (N 5 338).
The distributions of weekly Kt/V and CCr for patientsclearance component were determined. Fourth, the inde-
pendent association of the total and partitioned measures receiving CAPD and cycler dialysis are shown in Figures
1 and 2. Among patients with both adequacy measures,of clearance and mortality were analyzed, controlling
for other patient characteristics using logistic regression only 15.8% of CAPD patients and 14.2% of cycler pa-
tients had calculated adequacy measures that met themodels for each clearance measure separately. Finally,
we examined the association between DOQI recommen- National Kidney Foundation Dialysis Outcomes Quality
Initiative (DOQI-NKF) Guidelines.dations for adequate PD dose and mortality by conduct-
ing a series of logistic regression analyses that used di- On average, patients on cycler dialysis had a higher
Kt/V urea than patients on CAPD, but there was nochotomous variables for adequate weekly Kt/V, weekly
CCr, and both as independent predictors and mortality difference in CCr values by modality (Table 1). Women
had significantly higher average Kt/V urea values andas the outcome (dependent) variable. In each of these
models, we controlled for patient characteristics. significantly lower CCr values compared with men. Aver-
age CCr values were higher among whites than blacks
and among patients with ESRD secondary to diabetes
RESULTS
mellitus. In addition, mean Kt/V urea values tended to
Patients who were white and black, 18 years of age or decrease with increasing BMI or with increasing dialysis
greater, and who had received only PD in the Network duration. Among the 684 patients with both adequacy
from July 31, 1996, to December 31, 1996, were eligible measures, factors associated with inadequate dialysis, by
for inclusion in this analysis. There were 1512 eligible logistic regression, included longer duration of dialysis,
patients in the sample who were receiving treatment at greater BMI, male gender, black race, and absence of
54 centers. The mean (SD) number of patients sampled diabetes mellitus (Table 2).
per facility was 21.6 (6.2), and the 25th to 75th percentile Prescription data were available for 875 (98.4%) CAPD
range was 16 to 27. The PD modality was CAPD for patients and 497 (89.2%) cycler patients. The daily pre-
58.8%, cycler for 36.8%, and intermittent peritoneal dial- scription volume had a skewed distribution to the right
ysis (IPD) or unknown modality for 4.4% of patients. with median volumes of 8.0 L in CAPD patients, 10.0 L
Because of small numbers, patients from the IPD and in cycler patients with night dwells only, and 11.0 L in
unknown categories were excluded, leaving 1446 patients cycler patients with day and night dwells (Figs. 3 and 4).
to form the study group. The mean age of patients in On average, a typical CAPD patient was prescribed four
the cohort was 52.3 6 14.2 years; 51.2% were white. 2 L exchanges per day while the typical cycler patient
Forty-nine percent were male, and 31.6% had diabetes had five 2 L exchanges at night with a median dwell time
mellitus as the cause of ESRD. The median duration of of 90 minutes. Approximately 60% of cycler patients
dialysis was 1.8 years, and the mean BMI was 26.8 6 5.7 had at least one daytime dwell with a median volume of
kg/m2. Serum albumin measures were available for 611 4.0 L and a median dwell time of 420 minutes. Additional
patients, and the mean value was 3.62 6 0.53 g/dL. There prescription information is presented in Table 3. In
were no significant differences in these demographic and CAPD patients, there was a statistically significant in-
clinical variables between CAPD and cycler patients. crease in total prescribed volume as either BMI or dura-
Dialysis adequacy data in the six months before the tion of dialysis increased (Table 4). For cycler patients,
survey were not reported for all patients. Weekly Kt/V there was an increase in total prescribed volume as BMI
urea values were available for 70.5% of CAPD patients rose and a borderline significant increase in prescribed
and 74.0% of cycler patients. Weekly CCr values were volume as dialysis duration lengthened (Table 4).
available for 61.8% of CAPD patients and 64.6% of During the seven months of follow-up, there were
cycler patients. Both weekly Kt/V urea and CCr values 140 deaths among the cohort. By univariate analysis,
were reported for 60.5% of CAPD patients and 63.7% increasing age, white race, diabetic ESRD, and the pres-
of cycler patients (P 5 0.2). There were no differences ence of angina pectoris, congestive heart failure and a
in the rates of measuring PD adequacy by age, gender, history of myocardial infarction were each associated
cause of ESRD, duration of dialysis, or BMI; however, with increased risk of death. There was no difference
white patients were more likely to be missing both ade- in mortality rates by gender, PD modality, duration of
quacy measures compared with black patients (data not dialysis greater than one year, or BMI.
shown). When the dialysis and renal components of the ade-
Of the 873 patients who had at least one calculable quacy measures were examined separately, mean resid-
adequacy measure, the mean weekly Kt/V urea (mean 6 ual renal function was highest among patients who re-
SD) was 2.13 6 0.55, and the mean weekly CCr was 62.9 6 ceived the highest total dialysis dose (P , 0.001; Table 5).
20.4 L/week/1.73 m2. For those patients who were anuric, Mortality rates tended to be generally higher among
patients with lower total dialysis doses with a statisticallythe mean weekly Kt/V urea was 1.97 6 0.46, and the mean
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Fig. 1. Distribution of weekly Kt/V urea values in continuous ambulatory peritoneal dialysis (CAPD; A) and continuous cyclic PD (CCPD; B)
patients.
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Fig. 2. Distribution of weekly creatinine clearance (CCr) values in CAPD (A) and CCPD (B) patients.
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Table 2. Factors independently associated with inadequate dialysisTable 1. Associations between patient characteristics and dialysis
adequacy measures in a random sample of 1446 PD patients in as defined by DOQI Guidelines
ESRD Network 6
Odds ratio 95% CI P value
Average Average
Sex male 1.5 1.1–2.2 0.02weekly weekly % Below
Race Black 1.5 1.0–2.1 0.03Characteristic Na Kt/V Na CCr DOQI Cause of ESRD diabetes 0.7 0.5–1.0 0.04
Body mass indexAge years
18–44 262 2.12 220 62.4 87.1 ,23 Ref
23–25 1.0 0.6–1.7 0.8645–64 416 2.12 347 63.6 83.1
651 177 2.16 133 62.1 85.4 26–29 1.0 0.6–1.6 0.91
.29 1.9 1.1–3.2 0.01Race
Black 417 2.02c 373 60.6b 86.2 Dialysis duration years
,1 RefWhite 438 2.22 327 65.6 83.6
Gender 1–2 1.1 0.7–1.7 0.69
2–3.4 3.1 1.8–5.1 ,0.001Female 430 2.27c 350 61.0b 83.7
Male 425 1.98 349 64.8 86.0 3.51 3.8 2.3–6.2 ,0.001
Cause of ESRD
Other 573 2.09b 482 61.7b 86.3
Diabetes mellitus 282 2.19 218 65.8 81.7
Comorbid diabetes mellitus
No 833 2.13 683 63.0 84.7 models that also included all of the studied risk factors,
Yes 22 2.10 17 60.3 89.7
a 10 L/week/1.73 m2 increase in the urinary componentAngina pectoris
No 808 2.13 663 63.2 84.4 of weekly CCr was associated with a 40% decreased risk
Yes 47 2.07 37 59.1 91.4 of death (P , 0.001), and a 0.1 unit increase in the
Congestive heart failure
urinary component of weekly Kt/V urea was associatedNo 785 2.13 642 63.5b 84.6
Yes 70 2.06 58 57.0 87.4 with a 12% decreased risk of death (P , 0.003). In
Myocardial infarction contrast, the dialysate components of neither weekly CCrNo 824 2.13 672 63.1 84.6
nor weekly Kt/V urea were predictive of death.Yes 31 2.05 28 58.0 90.5
Modality
CAPD 516 2.07c 431 63.6 84.2
Cycler 339 2.21 269 61.8 85.8 DISCUSSION
Dialysis duration years
This report is the first study, to our knowledge, of the,1 239 2.27c 177 70.9c 77.4
1–2 213 2.19 174 66.1 82.1 association between the adequacy of PD and mortality
2–3.4 182 2.00 154 58.9 89.7 in a large, population-based random sample of adult
3.51 201 2.00 177 55.9 91.4
patients in the United States. More than one third ofBody Mass Index
,23 211 2.21c 167 59.5b 84.7 patients did not have an adequacy measure within a six-
23–25 223 2.19 182 64.8 80.6 month period; DOQI Guidelines that were published
26–29 197 2.14 163 65.4 82.1
after these data were collected recommend that ade-.29 224 1.97 188 62.1 87.6
quacy measures be performed every four months in an-a Number of patients with calculable adequacy measure
b P # 0.05 uric patients and every two months in patients with resid-
c P , 0.001 ual renal function. Of those patients who did have an
adequacy measure performed, more than 75% had a
dose of dialysis that was less than the DOQI guidelines
[5]. Patient characteristics associated with an increasedsignificant dose response relationship for weekly CCr, but
risk for inadequate dialysis included black race, absencenot for weekly Kt/V urea.
of diabetes mellitus, higher body surface area, and aIn separate logistic regression models that included
longer duration of dialysis, likely a surrogate measureall of the studied risk factors, an increase in weekly CCr
for residual renal function.was significantly associated with a decreased risk of death
Our report on the association between inadequate PD(P 5 0.01), while an increase in weekly Kt/V urea was
adequacy and mortality confirms and extends observa-of borderline significance in decreasing the risk of death
tions made in previous studies; however, there are differ-(P 5 0.08; Table 6). Other factors that were associated
ences in the methodology of these PD mortality studies.with an increased risk of death included increasing age,
Our study examined a random sample of prevalentdiabetes mellitus as the cause of ESRD, and a history
chronic PD patients in the southeastern United Statesof myocardial infarction. In this model, each 10 L/week
and utilized dose of dialysis observed over a six-monthincrease in weekly CCr was associated with a decline of
period of observation, and the multivariate analysis con-20% in the risk of mortality.
trolled for patient demographics, medical comorbidities,Additional logistic regression models were performed
BMI, and PD modality. The utilization of a randomusing separate variables for the urinary and peritoneal
components of dialysis adequacy (Table 7). In these sample of patients allows for greater generalizability of
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Fig. 3. Distribution of daily prescribed dialy-
sate volume in CAPD patients.
Fig. 4. Distribution of daily prescribed dialy-
sate volume in cycler PD patients.
study results. It avoids possible selection bias and allows decline in dialysis dose over time that occurred in the
CANUSA study was due to a decrease in residual renalfor the ascertainment of dose in peritoneal home training
units of varying sizes. The utilization of multivariate anal- function that was not compensated by a concomitant
increase in the prescribed peritoneal component of clear-yses allows for the statistical correction for potential
confounders of dialysis dose, such as body size and gen- ance. A second study that involved 2686 patients in the
United States demonstrated that although residual renalder, and provides a more robust analysis of variables
that are predictive of mortality. function was strongly associated with survival, there was
no relationship between peritoneal clearances and sur-Several other investigators have used multivariate
analysis to determine risk factors for mortality in chronic vival [19]. Each 10 L/week increase in residual renal
function was associated with a 12% reduction in the oddsPD patients. The Canada-USA (CANUSA) study ana-
lyzed risk factors for mortality in 680 incident chronic ratio for death. In this logistic regression model, other
predictors of death included increasing age and the pres-PD patients. The risk of death increased by 5% for each
0.1 unit decline in Kt/V urea and increased by 7% for ence of diabetes mellitus.
Several other smaller studies have analyzed the effecteach decrease of 5 L/1.73 m2/week in weekly CCr [10]. In
the CANUSA study, a repeated-measures design was of dialysis dose on mortality in chronic PD patients. A
study of 210 incident French patients receiving CAPDused to analyze the effect of dialysis dose over time. The
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Table 3. Dialysis prescription data
25th 75th
Mean percentile Median percentile
Single dwell volume mL
CAPD 2138 2000 2000 2500
Cycler day 1927 1700 2000 2000
Cycler night 2202 2000 2000 2500
Daily dwell volume mL
CAPD 8784 8000 8000 10000
Cycler day 4421 2000 4000 5000
Cycler night 10353 8000 10000 12000
Cycler day 1 night 12018 10000 11000 14000
Daily drain volume mL
CAPD 10384 8900 9850 11600
Cycler 13107 11046 12931 15000
Number of exchanges
CAPD (total) 4.1 4 4 4
Cycler (daytime) 2.2 1 2 3
Cycler (night) 4.8 4 5 5
Cycler (total) 6.2 5 6 7
Dwell time for single cycler exchange minutes
Single nighttime dwell 95 80 90 110
Single daytime dwell 457 240 420 720
Table 4. Influence of body mass index (BMI) and duration of that survival was improved if the mean weekly Kt/V
dialysis on prescribed dialysis volume
urea value was greater than 1.96 [9]. Other predictors of
Number of Volume mortality were older age and the presence of peripheral
patients in mL P vascular disease. Variables that were not predictive of
CAPD patients death included serum albumin level, protein catabolic
BMI
rate, and the presence of arrhythmia or dyslipidemia.,23 203 8411 ,0.001
23–25 211 8718 Dose of dialysis was modeled as a time-dependent covar-
26–29 203 8808 iate so that changes in dose of dialysis over time were
.29 195 9395
reflected in the final multivariate model. In a study ofDialysis duration years
,1 229 8504 ,0.001 51 prevalent U.S. CAPD patients followed for up to five
1–2 220 8490 years, risk factors for mortality included age, duration
2–3.4 172 8862
on CAPD, serum albumin level, and weekly Kt/V urea..3.4 235 9253
Cycler patients In this study, a single variable was used to denote the
BMI presence of up to three comorbid medical conditions,
,23 132 11203 50.01
namely diabetes mellitus, hypertension, and atheroscle-23–25 130 12008
26–29 109 12447 rotic heart disease [8].
.29 135 12650 In a prevalent cohort of dialysis patients, we found
Dialysis duration years
that the renal dose of dialysis was a statistically significant,1 130 11226 50.04
1–2 159 12062 predictor of death, while the peritoneal dose was not.
2–3.4 124 12167 Our findings are thus consistent with the findings from
.3.4 109 12504
the study of Diaz-Buxo et al [19], as well as those from
a In patients with at least one daytime dwell a random sample of American patients followed in the
Health Care Financing Administration Core Indicators
Project (abstract; Rocco et al, J Am Soc Nephrol 9:255A,
1999). The potential implications of these findings as wellreported better survival among patients with a weekly
Kt/V urea greater than 1.7 and a weekly CCr greater as the limitations of these findings were well reviewed by
Diaz-Buxo et al. It is now possible to expound furtherthan 50 L/week/1.73 m2 [20]. Other variables that were
predictive of mortality included older age, the presence on these findings based on the data from these two addi-
tional analyses from separate databases.of comorbid factors (malignancy, multisystem disease,
infection, pulmonary insufficiency, and cirrhosis), and The four hypotheses proposed by the Diaz-Buxo group
were that: (1) there were abnormalities or errors in thethe presence of either cardiovascular disease and hyper-
triglyceridemia. Serum albumin levels were not pre- data; (2) other processes may be more important than
peritoneal clearance in predicting survival; (3) peritonealdictive of death in this model. A study of 68 prevalent
Italian dialysis patients followed for three years found clearance may not be a sensitive marker of survival; or
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Table 5. Associations between adequacy measures and death
Mean Mean Median Number Mortality
Weekly Kt/V range Na total Kt/V dialysis Kt/V urinary Kt/V deaths rateb RR (CI)
2.421 214 2.87 2.12 0.67 14 0.33 1.0
2.04–2.41 214 2.21 1.93 0.06 20 0.49 1.5 (0.7–2.9)
1.74–2.03 214 1.89 1.74 0.00 19 0.46 1.4 (0.7–2.8)
,1.74 213 1.53 1.46 0.00 23 0.56 1.7 (0.9–3.3)
Trend P 5 0.16
Mean Mean Median Number Mortality
Weekly CCr range Na total CCr dialysis CCr urinary CCr deaths rateb RR (CI)
72.81 175 90.9 55.9 34.4 8 0.23 1.0
58.0–72.7 175 65.0 53.1 10.5 12 0.35 1.5 (0.6–3.7)
49.3–57.9 175 53.6 49.7 0.0 13 0.37 1.6 (0.7–3.8)
,49.3 175 42.3 40.9 0.0 22 0.67 2.9 (1.3–6.4)
Trend P 5 0.01
a Number of patients with an adequacy measure. Eight hundred fifty-five patients had at least one Kt/V value, and 700 patients had at least one creatinine clearance
value.
b Rate is deaths per 1,000 dialysis days
(4) high peritoneal clearances may be associated not only dialysis patients, the variables of age and serum albumin
are usually stronger predictors of death than dose ofwith enhanced solute removal, but also with a mortality
producing process. We believe that it is unlikely that the dialysis. In addition, in both hemodialysis and PD pa-
tients, black patients have a lower mortality rate thandata were flawed. Data from the HCFA Core Indicators
Project have shown that the increase in dose of dialysis white patients. The explanation for this difference is not
entirely understood, but may be related to differenceshas been accompanied by an increase in the volume of
dialysate used [13]. This observation implies that the in nutritional status or medical comorbidities between
blacks and whites [23–25]. In PD patients, some investi-measurement of peritoneal clearances by patients and
clinics is reasonably accurate. Compliance with the peri- gators have found that risk of death increases as the
dialysis/plasma ratio (D/P) of creatinine increases [26–29].toneal prescription is of increasing concern. Data from
American patients suggest that approximately 25% of This observation has not been universal, however, as
other investigators have found no relationship betweenpatients miss one or more treatments per week [21] and
that patients may shorten some treatments to accommo- peritoneal transport characteristics and death [19, 20].
Most of these studies were cross sectional, and it wasdate personal activities [22]. Either of these actions would
result in decreased peritoneal clearances. It is possible not possible to differentiate between those patients who
have stable peritoneal transport characteristics and thosethat patients may be more noncompliant as they lose
residual renal function, since their prescription may re- whose peritoneal transport characteristics vary over time.
There is some evidence to suggest that an increase inquire higher dwell volumes, additional exchanges, or
longer amounts of time on the cycler; however, the au- peritoneal transport rate may be due to a state of chronic
inflammation caused by either the development or wors-thors are unaware of such data.
There is much controversy in the dialysis community ening of chronic medical conditions [30]. Additional
study of peritoneal transport rates using longitudinalregarding the relative importance of urea kinetics versus
creatinine kinetics in predicting mortality. In the CANUSA data will probably be needed in order to investigate
more fully the relationship between peritoneal transportstudy, creatinine kinetics appeared to be a stronger pre-
dictor than urea kinetics in predicting mortality. In our characteristics and mortality. High peritoneal clearances
may also be a surrogate for other potential modifiers ofstudy, we found that CCr was predictive of death, while
the Kt/V urea trend was not statistically significant. Our mortality rate. These modifiers include potential associa-
tions between delivered dialysis dose and overall compli-findings do not necessarily imply that Kt/V urea is not
a predictor of death; we had a relatively short follow-up ance with the patient’s medical regimen, including diet,
medications, excellence in medical care provided by phy-period with a small number of deaths, and thus, our event
rate may not have been high enough to detect a differ- sicians, and provision of an adequate dose of dialysis. A
randomized clinical trial of dialysis dose in PD patientsence in death rates based on Kt/V urea clearance values.
There may be factors other than the peritoneal dose is needed to answer these and other questions regarding
the effects of confounders of dialysis dose and mortality.of dialysis that are important in predicting survival in
PD patients. Certainly increasing age and decreasing It is also conceivable that an increase in the solute
removal rate, as measured by peritoneal clearances, isserum albumin levels are strong predictors of mortality
in both PD and hemodialysis patients. Indeed, for hemo- also associated with other effects that result in an in-
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Table 7. Factors independently associated with death using separateTable 6. Factors independently associated with death using
total clearance values components for urinary and peritoneal components of adequacy
Odds ratioOdds ratio
Factor (95% CI) P value Factor (95% CI) P value
Factors independently associated withFactors independently associated with death
(weekly CCr model) death (weekly CCr model)
Age (10 year increase) 1.4 (1.1–1.8) 0.01Weekly CCr (per 10 unit increase) 0.8 (0.7–0.9) 0.01
Diabetic ESRD (vs. all others) 2.2 (1.2–4.2) 0.01 Diabetic ESRD (vs. all others) 2.4 (1.3–4.6) 0.01
Weekly urinary CCrAge (per 10 year increase) 1.4 (1.1–1.7) 0.01
Myocardial infarction 3.2 (1.0–10.2) 0.04 (10 L/week/1.73 m2 increase) 0.6 (0.4–0.8) ,0.001
Weekly dialysate CCrFactors independently associated with death
(weekly Kt/V urea model) (10 L/week/1.73 m2 increase) 0.9 (0.7–1.2) 0.41
Factors independently associated withAge (per 10 year increase) 1.3 (1.1–1.6) 0.003
Diabetic ESRD (vs. all others) 1.9 (1.1–3.2) 0.02 death (weekly Kt/V urea model)
Age (10 year increase) 1.3 (1.1–1.6) 0.003Myocardial infarction 3.6 (1.3–10.1) 0.02
Weekly Kt/V (per unit increase) 0.6 (0.4–1.1) 0.08 Diabetic ESRD (vs. all others) 1.9 (1.1–3.3) 0.01
White race (vs. black) 1.9 (1.1–3.3) 0.02Factors (in addition to dialysis adequacy measures) included in logistic regres-
Myocardial infarction 3.3 (1.1–10.0) 0.03sion models were: age; race; sex; cause of ESRD; comorbid diabetes; history of
Weekly urinary Kt/Vangina, congestive heart failure, and myocardial infarction; dialysis modality;
(0.1 unit increase) 0.88 (0.81–0.96) 0.003dialysis duration; and body mass index.
Weekly dialysate Kt/V urea
(0.1 unit increase) 1.0 (0.9–1.1) 0.81
Factors (in addition to dialysis adequacy measures) included in logistic regres-
sion models were: age; race; sex; cause of ESRD; comorbid diabetes; history of
crease in mortality rates. One potential mechanism dis- angina, congestive heart failure, and myocardial infarction; dialysis modality;
dialysis duration; and body mass index.cussed by Diaz-Buxo et al is the hypothesis that higher
D/P creatinines are associated with higher peritoneal
clearances, and thus, the potential improvements in mor-
tality from higher doses of dialysis are offset by higher deviations for these adequacy values were 19.5% higher
mortality rates from high peritoneal transport rates. With for Kt/V urea and 47.8% higher for CCr in patients with
no change in ultrafiltration rates, each 0.1 unit increase residual renal function compared with anuric patients.
in D/P creatinine results in an increase in peritoneal Second, in order to evaluate more completely the poten-
clearance of creatinine of about 7 L/week/1.73 m2. Based tial role of peritoneal clearances on mortality, it will
on PET data, however, each 0.1 unit increase in D/P probably be necessary to study patients who are anuric
creatinine ratios is also associated with about a 250 mL/ and who receive a wide range of peritoneal clearances.
day decrease in ultrafiltration. Thus, the net sum of a This range in peritoneal clearances is not observed in
0.1 unit increase in D/P creatinine is an increase in clear- current databases in the United States [13, 31]; therefore,
ance of less than 6 L/week/1.73 m2. Thus, if the Diaz- this analysis will probably require a randomized study
Buxo et al hypothesis is correct, then the decrease in comparing a delivered dose of dialysis of 60 L/week/1.73
mortality from higher peritoneal clearances is less than m2 (in CAPD patients) versus a higher dose in the range
the increase in mortality rates from other etiologies, such of 75 to 80 L/week/1.73 m2.
as increased protein loss. An alternative explanation is that peritoneal and renal
Our findings do not necessarily imply that the perito- clearances are not equal such that 1 mL/min of residual
neal component of dialysis clearance is not important as renal function provides “more” clearance than 1 mL/
a predictor of mortality. An analysis of Table 6 indicates min of peritoneal clearance. Among the anuric patients
that there was great variability in residual renal function in our study, the mean weekly Kt/V urea and CCr levels
values, but much less variability in peritoneal clearance were both just slightly less than NKF-DOQI recommen-
values. In addition, those patients with higher levels of dations. Nonetheless, the peritoneal clearances were not
CCr had a substantial portion of their clearance provided predictive of mortality. Possible explanations for the
by residual renal function; conversely, only about 25% nonequivalence of peritoneal and renal clearances in-
of anuric patients had a CCr greater than 60 L/week or clude variability of the peritoneal clearance of larger
a weekly Kt/V urea greater than 2.2. Two conclusions solutes [32], daily variability in peritoneal clearances of
may be drawn from these observations. First, the pre- urea and creatinine [33], and noncompliance with the
dictive ability of renal, but not peritoneal clearances for PD prescription [21]. If this hypothesis is substantiated
mortality may be partly, if not mostly due to the greater by additional investigations, the benefits of early start
variability of the renal versus the peritoneal component dialysis are minimized, and adequacy guidelines will
of dialysis adequacy. On average, patients with residual need to be modified to reflect the nonequivalency of
renal function had a Kt/V urea that was 0.16 units higher peritoneal and renal clearances.
and a weekly CCr that was 9.2 L/week/1.73 m2 higher Until more data are available, it seems prudent to pre-
serve residual renal function as much as possible. Avoid-than patients who were anuric. In addition, the standard
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